By use of a large NSCLC cohort from The Cancer Genome Atlas (TCGA) database, our data showed that in lung cancer patients carrying wild-type TP53, FOSB expression betokened a positive prognosis; whereas in those carrying mutant TP53, it correlated with a poor one. Here, TP53 is linked to lung cancer.